株探米国株
日本語 英語
エドガーで原本を確認する
false 0001892322 0001892322 2024-05-14 2024-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): May 14, 2024

 

HEARTCORE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41272   87-0913420

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

1-2-33, Higashigotanda, Shinagawa-ku, Tokyo, Japan

(Address of principal executive offices)

 

+81-3-6409-6966

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HTCR   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On May 14, 2024, HeartCore Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in any website is not a part of this Current Report on Form 8-K.

 

The information included in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

No.

  Description
99.1   Press release of the registrant dated May 14, 2024.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEARTCORE ENTERPRISES, INC.
   
Dated: May 14, 2024 By: /s/ Sumitaka Yamamoto
  Name: Sumitaka Yamamoto
  Title: Chief Executive Officer

 

 

EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

HeartCore Reports First Quarter 2024 Financial Results

 

NEW YORK and TOKYO, May 14, 2024 (GLOBE NEWSWIRE) – HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the first quarter ended March 31, 2024.

 

First Quarter 2024 and Recent Operational Highlights

 

  Sold a Go IPO Client Warrant for $9 million. During the first quarter ended March 31, 2024, the Company received $5 million, with the remaining $4 million received in April 2024. Due to specific accounting treatments and stipulations in the warrant agreement, HeartCore will not recognize the $9 million as revenue on the balance sheet until the client becomes a publicly listed company, which is expected to occur in Fall 2024.
  Disbursed first dividend payment of $0.02 per share on May 3, 2024
  Expanded partnership with Heart-Tech Health
  Engaged with Onside Content to develop AI-based content marketing evaluation and reporting index solution
  Formed an Artificial Intelligence Software Development Division
  Signed 12th, 13th, and 14th Go IPO Contract
  Established HeartCore Luvina Vietnam Co., Ltd., a joint venture with Luvina Software Joint Stock Company
  Signed with Toshiba Elevator and Building Systems Corporation to implement its CMS platform

 

Management Commentary

 

“The first quarter brought promising developments for our software business, marking a pivotal shift as this division turned profitable for the quarter,” said HeartCore CEO Sumitaka Kanno Yamamoto. “This success stems from our proactive cost reduction initiatives without having taken our foot off the gas pedal from a sales & marketing standpoint, which have significantly improved our margins in this division. Moreover, the establishment of two new divisions within HeartCore has bolstered this momentum, demonstrating encouraging traction since its inception and contributing to the profitability of our software arm. We believe that our strategic joint venture and partnership with Luvina Software Joint Stock Company offers a dependable and cost-effective IT outsourcing and software development partner, with forecasts projecting roughly $1 million in sales within its first year, which is all attributable to HeartCore’s P&L. Additionally, our recently formed AI software development division has already secured two deals within its first month, signaling promising opportunities for further expansion of our enterprise software capabilities and customer portfolio.”

 

“Additionally, though the optics of our quarterly results reflect a decline, it’s crucial to note that these figures do not encompass the significant sale of a Go IPO client warrant in March that totaled $9 million. As we explained in a previous press release yesterday, a total of $9 million was received by our team following the sale of a Go IPO’s client’s warrants in Q1 2024, but due to specific accounting treatments and stipulations, we cannot record this amount as revenue unless and until the client goes public. Despite this accounting nuance, we’ve already put the capital to work by allocating it to various strategic initiatives, including our dividend payment which was disbursed on May 3rd.”

 

First Quarter 2024 Financial Results

 

Revenues were $5.0 million compared to $8.7 million in the same period last year. The decrease was primarily due to lower revenues from GO IPO consulting services as the Company’s two IPO consulting customers successfully listed on the Nasdaq in the same quarter last year, offset by increases in revenue from the sale of on-premises software, and customized software development and services.

 

Gross profit decreased to $2.0 million compared to $5.6 million in the same period last year. The decrease was primarily due to the aforementioned reason above.

 

 

 

Operating expenses decreased to $2.7 million compared to $3.3 million in the same period last year. The decrease was primarily due to lower selling expenses and general and administrative expenses.

 

Net loss was about $1.5 million or $(0.06) per diluted share compared to a net income of $1.8 million or $0.10 per diluted share, in the same period last year.

 

As of March 31, 2024, the Company had cash and cash equivalents of $1.2 million compared to $1.0 million on December 31, 2023.

 

2024 Strategic Outlook

 

HeartCore CEO Sumitaka Kanno Yamamoto added: “Looking forward to the remainder of the year, our focus remains on expanding our enterprise software business through ongoing cost reduction strategies and identifying synergistic opportunities with our subsidiaries and divisions to optimize operational efficiencies and capabilities. Building on the momentum of a profitable quarter within this arm, we remain committed to sustaining this trajectory throughout 2024 as we strive towards overall profitability. Additionally, our dedicated Go IPO team continues to uphold its white-glove approach, guiding our expanding pipeline of clients through the comprehensive IPO process. With an optimistic outlook on the IPO market, we anticipate announcing the completion of several IPOs this year and reaping the benefits of additional Go IPO warrants.”

 

About HeartCore Enterprises, Inc.

 

Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company’s products and services is available at and https://heartcore-enterprises.com/.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

 

HeartCore Investor Relations Contact:

 

Gateway Group, Inc.

Matt Glover and John Yi

HTCR@gateway-grp.com

(949) 574-3860

 

 

 

HEARTCORE ENTERPRISES, INC.

CONSOLIDATED BALANCE SHEETS

 

    March 31,     December 31,  
    2024     2023  
    (Unaudited)        
ASSETS                
                 
Current assets:                
Cash and cash equivalents   $ 1,219,251     $ 1,012,479  
Accounts receivable     3,086,203       2,623,682  
Investments in marketable securities     408,266       642,348  
Investment in equity securities     -       300,000  
Prepaid expenses     3,942,371       536,865  
Current portion of long-term note receivable     100,000       100,000  
Due from related party     41,948       44,758  
Other current assets     223,222       234,761  
Total current assets     9,021,261       5,494,893  
                 
Non-current assets:                
Property and equipment, net     688,826       763,730  
Operating lease right-of-use assets     2,271,955       2,467,889  
Intangible asset, net     4,356,250       4,515,625  
Goodwill     3,276,441       3,276,441  
Long-term investment in equity securities     300,000       -  
Long-term investment in warrants     1,325,421       2,004,308  
Long-term note receivable     200,000       200,000  
Deferred tax assets     381,307       369,436  
Security deposits     325,267       348,428  
Long-term loan receivable from related party     160,974       182,946  
Other non-current assets     22,566       71  
Total non-current assets     13,309,007       14,128,874  
                 
Total assets   $ 22,330,268     $ 19,623,767  
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY                
                 
Current liabilities:                
Accounts payable and accrued expenses   $ 2,015,959     $ 1,757,038  
Accrued payroll and other employee costs     550,916       723,305  
Due to related party     256       1,476  
Short-term debt     66,081       135,937  
Current portion of long-term debts     446,601       371,783  
Insurance premium financing     157,917       -  
Factoring liability     179,414       562,767  
Operating lease liabilities, current     374,671       396,535  
Finance lease liabilities, current     16,512       17,445  
Income tax payables     150,174       162,689  
Deferred revenue     1,791,697       2,166,175  
Other current liabilities     5,268,130       216,405  
Total current liabilities     11,018,328       6,511,555  
                 
Non-current liabilities:                
Long-term debts     1,524,485       1,770,352  
Operating lease liabilities, non-current     1,959,671       2,135,160  
Finance lease liabilities, non-current     58,087       66,779  
Deferred tax liabilities     1,219,750       1,264,375  
Other non-current liabilities     191,933       208,732  
Total non-current liabilities     4,953,926       5,445,398  
                 
Total liabilities     15,972,254       11,956,953  
                 
Shareholders’ equity:                
Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023)     -       -  
Common shares ($0.0001 par value, 200,000,000 shares authorized; 20,864,144 and 20,842,690 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively)     2,085       2,083  
Additional paid-in capital     19,686,511       19,594,801  
Accumulated deficit     (16,096,819 )     (14,763,469 )
Accumulated other comprehensive income     347,087       331,881  
Total HeartCore Enterprises, Inc. shareholders’ equity     3,938,864       5,165,296  
Non-controlling interests     2,419,150       2,501,518  
Total shareholders’ equity     6,358,014       7,666,814  
                 
Total liabilities and shareholders’ equity   $ 22,330,268     $ 19,623,767  

 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITEDCONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

   

For the three

months ended

March 31, 2024

   

For the three

months ended

March 31, 2023

 
             
Revenues   $ 5,046,732     $ 8,734,150  
Cost of revenues     3,014,543       3,101,066  
Gross profit     2,032,189       5,633,084  
                 
Operating expenses:                
Selling expenses     219,707       568,642  
General and administrative expenses     2,406,303       2,685,207  
Research and development expenses     89,134       79,624  
Total operating expenses     2,715,144       3,333,473  
                 
Income (loss) from operations     (682,955 )     2,299,611  
                 
Other income (expenses):                
Changes in fair value of investments in marketable securities     (234,082 )     -  
Changes in fair value of investments in warrants     (678,887 )     193,365  
Interest income     2,594       31,605  
Interest expenses     (36,661 )     (39,840 )
Government grants     -       -  
Other income     97,016       14,201  
Other expenses     (25,194 )     (29,457 )
Total other income (expenses)     (875,214 )     169,874  
                 
Income (loss) before income tax provision     (1,558,169 )     2,469,485  
                 
Income tax expense (benefit)     (80,167 )     661,448  
                 
Net income (loss)     (1,478,002 )     1,808,037  
Less: net loss attributable to non-controlling interests     (144,652 )     (74,252 )
Net income (loss) attributable to HeartCore Enterprises, Inc.   $ (1,333,350 )   $ 1,882,289  
                 
Other comprehensive income (loss):                
Foreign currency translation adjustment     10,295       (25,034 )
                 
Total comprehensive income (loss)     (1,467,707 )     1,783,003  
Less: comprehensive loss attributable to non-controlling interests     (149,563 )     (76,542 )
Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.   $ (1,318,144 )   $ 1,859,545  
                 
Net income (loss) per common share attributable to HeartCore Enterprises, Inc.                
Basic   $ (0.06 )   $ 0.10  
Diluted   $ (0.06 )   $ 0.10  
                 
Weighted average common shares outstanding                
Basic     20,854,714       19,066,160  
Diluted     20,854,714       19,066,160  

 

 

 

HEARTCORE ENTERPRISES, INC.

UNAUDITEDCONSOLIDATED STATEMENTS OF CASH FLOWS

 

   

For the three

months ended

March 31, 2024

   

For the three

months ended

March 31, 2023

 
             
Cash flows from operating activities                
Net income (loss)   $ (1,478,002 )   $ 1,808,037  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
Depreciation and amortization expenses     188,085       123,312  
Amortization of debt issuance costs     1,173       758  
Non-cash lease expense     93,133       76,017  
Deferred income taxes     (80,780 )     (17,284 )
Stock-based compensation     91,712       915,228  
Warrants received as noncash consideration     -       (4,009,335 )
Changes in fair value of investments in marketable securities     234,082       -  
Changes in fair value of investments in warrants     678,887       (193,365 )
Gain on termination of lease     (469 )     -  
Changes in assets and liabilities:                
Accounts receivable     (523,110 )     (66,833 )
Prepaid expenses     (3,257,972 )     (45 )
Other assets     (18,618 )     78,241  
Accounts payable and accrued expenses     295,799       (94,363 )
Accrued payroll and other employee costs     (149,603 )     (178,733 )
Due to related party     (1,161 )     2,544  
Operating lease liabilities     (90,035 )     (73,147 )
Income tax payables     (2,387 )     678,725  
Deferred revenue     (300,011 )     (167,873 )
Other liabilities     5,060,658       70,057  
Net cash flows provided by (used in) operating activities     741,381       (1,048,059 )
                 
Cash flows from investing activities                
Purchases of property and equipment     -       (9,409 )
Repayment of loan provided to related party     10,814       11,955  
Payment for acquisition of subsidiary, net of cash acquired     -       (724,910 )
Net cash flows provided by (used in) investing activities     10,814       (722,364 )
                 
Cash flows from financing activities                
Payments for finance leases     (4,474 )     (5,658 )
Proceeds from short-term debt     68,138       -  
Repayment of short-term and long-term debts     (207,486 )     (265,255 )
Repayment of insurance premium financing     (14,772 )     (36,517 )
Net proceeds from factoring arrangement     -       173,582  
Net repayment of factoring arrangement     (383,353 )     -  
Payments for debt issuance costs     -       (448 )
Capital contribution from non-controlling shareholder     67,195       -  
Net cash flows used in financing activities     (474,752 )     (134,296 )
                 
Effect of exchange rate changes     (70,671 )     (62,692 )
                 
Net change in cash and cash equivalents     206,772       (1,967,411 )
                 
Cash and cash equivalents - beginning of the period     1,012,479       7,177,326  
                 
Cash and cash equivalents - end of the period   $ 1,219,251     $ 5,209,915  
                 
Supplemental cash flow disclosures:                
Interest paid   $ 37,098     $ 16,968  
Income taxes paid   $ 117,524     $ -  
                 
Non-cash investing and financing transactions                
Operating lease right-of-use assets obtained in exchange for operating lease liabilities   $ 125,735     $ -  
Insurance premium financing   $ 172,689     $ 389,035  
Liabilities assumed in connection with purchase of property and equipment   $ -     $ 6,288  
Common shares issued for acquisition of subsidiary   $ -     $ 3,150,000